Concepedia
Statistics
Publications
5
Citations
471
H-Index
Active since
1992
Affiliations
National Cancer Institute(Current)
Louisiana State University in Shreveport
M. Weinberger is an author at National Cancer Institute specializing in medicine, oncology, and pharmacotherapy.
Top concepts
MedicineOncologyPharmacologyPharmacotherapyUrologyDrug DiscoveryPharmacokineticsBusinessStabilityCancer Therapy
Publications per year
1992–1998
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.
Alain Thibault, Michael R. Cooper, William D. Figg et al. · PubMed · 1994 · 157 citations
Medicinal Chemistry, Pharmacological Study, Medicine +13
Surprising Activity of Flutamide Withdrawal, When Combined With Aminoglutethimide, in Treatment of "Hormone-Refractory" Prostate Cancer
Oliver Sartor, Michael R. Cooper, M. Weinberger et al. · JNCI Journal of the National Cancer Institute · 1994 · 138 citations
Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer
Oliver Sartor, M. Weinberger, Andrea Moore et al. · Urology · 1998 · 94 citations
Urology, Genitourinary Cancer, Medicine +6
Adaptive control with feedback strategies for suramin dosing
Michael R. Cooper, Ronald Lieberman, Renato V. La Rocca et al. · Clinical Pharmacology & Therapeutics · 1992 · 42 citations
Therapeutic Drug Monitoring, Control Method, Feedback Strategies +14
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response
Christopher Bowden, William D. Figg, Nancy A. Dawson et al. · Cancer Chemotherapy and Pharmacology · 1996 · 40 citations
Urology, Oncology, Phase I/ii Study +7
1–5 of 5